Wall Street Zen Upgrades Option Care Health (NASDAQ:OPCH) to Buy

Option Care Health (NASDAQ:OPCH) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday.

Other analysts have also recently issued reports about the company. Morgan Stanley initiated coverage on Option Care Health in a research report on Friday, October 17th. They set an “overweight” rating and a $35.00 price objective on the stock. Cowen started coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Option Care Health in a research note on Tuesday, November 25th. Citizens Jmp decreased their price objective on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a report on Friday, October 31st. Finally, Barrington Research reissued an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $35.67.

Option Care Health Trading Down 0.0%

NASDAQ:OPCH opened at $29.89 on Friday. The company has a 50-day moving average price of $28.25 and a 200-day moving average price of $29.30. The stock has a market cap of $4.74 billion, a price-to-earnings ratio of 23.72, a P/E/G ratio of 2.11 and a beta of 0.79. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. Option Care Health has a 12 month low of $22.29 and a 12 month high of $35.53.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of Option Care Health stock in a transaction dated Monday, November 3rd. The stock was purchased at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the acquisition, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the company’s stock in a transaction that occurred on Tuesday, September 9th. The stock was purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors have recently made changes to their positions in the company. USA Financial Formulas purchased a new position in Option Care Health in the 2nd quarter worth approximately $26,000. Cornerstone Planning Group LLC boosted its stake in Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares in the last quarter. Advisory Services Network LLC purchased a new position in shares of Option Care Health in the third quarter worth $35,000. Finally, McIlrath & Eck LLC purchased a new position in shares of Option Care Health in the second quarter worth $37,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.